QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 217 filers reported holding QIAGEN NV in Q3 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $938 | -99.8% | 20,424 | +74.9% | 0.09% | +79.2% |
| Q3 2022 | $482,000 | +0.8% | 11,680 | +19.7% | 0.05% | -14.3% |
| Q1 2022 | $478,000 | -64.9% | 9,760 | -60.2% | 0.06% | -62.9% |
| Q4 2021 | $1,361,000 | +81.2% | 24,492 | +57.7% | 0.15% | +98.7% |
| Q2 2021 | $751,000 | -2.2% | 15,530 | -33.3% | 0.08% | -43.7% |
| Q3 2019 | $768,000 | +134.9% | 23,279 | +188.5% | 0.14% | +145.5% |
| Q2 2019 | $327,000 | +31.9% | 8,068 | +11.9% | 0.06% | +27.9% |
| Q4 2018 | $248,000 | -15.9% | 7,210 | -7.4% | 0.04% | +4.9% |
| Q3 2018 | $295,000 | -56.0% | 7,785 | -62.4% | 0.04% | -59.0% |
| Q1 2018 | $670,000 | +110.0% | 20,714 | +100.5% | 0.10% | +75.4% |
| Q4 2017 | $319,000 | +43.7% | 10,330 | +56.3% | 0.06% | +35.7% |
| Q2 2017 | $222,000 | -29.1% | 6,610 | -38.7% | 0.04% | -42.5% |
| Q1 2017 | $313,000 | – | 10,787 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |